Forecast on Anticoagulants-Competitive Landscape & Pipeline Insights[2015]

Submitted by: Submitted by

Views: 10

Words: 782

Pages: 4

Category: Business and Industry

Date Submitted: 11/24/2015 12:50 AM

Report This Essay

Forecast on Anticoagulants-Competitive Landscape & Pipeline Insights[2015]

Bharat Book Bureau provides the report, on “Forecast on Anticoagulants-Competitive Landscape & Pipeline Insights[2015] ” The report analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. https://www.bharatbook.com/healthcare-market-research-reports-732713/anticoagulants-competitive-landscape-pipeline.html

24th Nov 2015- Mumbai, India: Bharatbook. com announces a report “Forecast on Anticoagulants - Competitive Landscape & Pipeline Insights[2015] ” The report analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.The Anticoagulants’ market is expected to decline after 2018 as many anticoagulants are going to be generic.

The Report, “Anticoagulants-Competitive Landscape, & Pipeline Insights, 2015” analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coronary Syndrome, Stroke and Myocardial Infarction. The new report analysis predicts that global VTE therapeutics market was worth USD 4 billion in 2014 and expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29%.The report analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.The Anticoagulants’ market is expected to decline after 2018 as many anticoagulants are going to be generic.

Scope

-Overview of Anticoagulants, which includes its physiology, pathophysiology, diagnosis and treatment.

-Report has covered the...